Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Multiple Myeloma × Filgrastim × Clear all

Phase

Status

Completed 61 Terminated 20 Unknown 7 Withdrawn 5 Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Myeloid, Acute 6 Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Neoplasms 4 Myelodysplastic Syndromes 4 Lymphoma, Non-Hodgkin 4 Hodgkin Disease 3 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Lymphoma 2 Leukemia, Myelomonocytic, Juvenile 2 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2 Leukemia, Biphenotypic, Acute 2 Carcinoma, Non-Small-Cell Lung 2 Burkitt Lymphoma 2 Sarcoma, Myeloid 1 Rhabdomyosarcoma 1 Retinoblastoma 1 Neutropenia 1 Myeloproliferative Disorders 1 Multiple Myeloma 1 Multi-centric Castleman's Disease 1 Medulloblastoma 1 Macular dystrophy, corneal type 1 1 Lymphoproliferative Disorders 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lymphoma, AIDS-Related 1 Lymphadenopathy 1 Leukemia, Myeloid, Accelerated Phase 1 Leukemia, Large Granular Lymphocytic 1

Interventions

Dexamethasone 105 Lenalidomide 73 daratumumab 54 Bortezomib 48 carfilzomib 35 pomalidomide 32 Calcium Dobesilate 30 Cyclophosphamide 25 isatuximab 19 belantamab mafodotin 16 Biopsy 13 Specimen Handling 12 dexamethasone acetate 11 dexamethasone 21-phosphate 11 Melphalan 11 selinexor 10 ixazomib 10 auricularum 10 Magnetic Resonance Spectroscopy 10 fludarabine 9 iberdomide 8 elotuzumab 8 talquetamab 6 nirogacestat 6 fludarabine phosphate 6 trametinib 5 Thalidomide 5 Etoposide 5 venetoclax 4 tocilizumab 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03188172 2024-05-14

MUKnineb

University of Leeds

Phase 2 Active not recruiting

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡